Virtu Financial LLC

Position in SNGX — Soligenix, Inc.

CIK 1533964 New York, NY

Position in SNGX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$24,361

+$4,105 QoQ

Shares Held

60,903

+302.9% QoQ

Ownership

0.280%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 13 holders

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Virtu Financial LLC holds $37,902,008 across 148 Biotechnology names. SNGX ranks #108 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	58,459	$4,130,128
2	APGE	Apogee Therapeutics, Inc.	29,790	$3,954,026
3	ABVX	Abivax S.A.	19,155	$2,552,595
4	AXSM	Axsome Therapeutics, Inc.	9,220	$2,256,779
5	KYMR	Kymera Therapeutics, Inc.	12,556	$1,439,796
6	PTGX	Protagonist Therapeutics, Inc	8,163	$1,000,620
7	TGTX	Tg Therapeutics, Inc.	17,524	$962,768
8	IOVA	Iovance Biotherapeutics, Inc.	221,500	$921,440

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$24,361	60,903	+302.9%	Shares	Defined	2026-08-13
2025-12-31	$20,256	15,117	-70.3%	Shares	Defined	2026-02-23
2025-09-30	$59,002	50,864	+259.6%	Shares	Defined	2025-11-14
2023-06-30	$9,900	14,144	-74.2%	Shares	Defined	2023-07-27
2022-09-30	$24,144	54,874	+148.2%	Shares	Defined	2022-11-07
2022-03-31	$16,137	22,106	-57.4%	Shares	Defined	2022-05-17
2021-09-30	$55,063	51,947	-35.6%	Shares	Defined	2021-11-12
2021-06-30	$89,538	80,665	-37.0%	Shares	Defined	2021-09-17
2021-03-31	$195,940	128,066	+190.4%	Shares	Defined	2021-05-19
2020-12-31	$56,441	44,095	-1.7%	Shares	Defined	2021-02-24
2020-09-30	$80,281	44,850	+6.6%	Shares	Defined	2020-12-11
2020-06-30	$88,780	42,076	—	Shares	Defined	2020-08-07
No filing history on record for this holder in this stock.